| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |